References
Bartlett, J. B. Clostridium difficile: clinical considerations. Rev. Infect. Dis. 12 (Suppl. 2) (1990) 243–251.
Ruf, B., Pohle, H. D. Role of clindamycin in the treatment of acute toxoplasmosis of the central nervous system. Eur. J. Clin. Microbiol. Infect. Dis. 3 (1991) 183–186.
Toma, E. Clindamycin/primaquine for treatment ofPneumocystis carinii in AIDS. Eur. J. Clin. Microbiol. Infect. Dis. 3 (1991) 210–213.
Hutin, J., Molina, J. M., Casin, I., Daix, V., Sednaoui, P., Welker, J., Lagrange, P., Decazes, J. M., Modai, J. Risk factors forClostridium difficile-associated diarrhea in HIV-infected patients. AIDS 7 (1993) 1441–1447.
Pear, S. M., Williamson, T. H., Bettin, K. M., Gerding, D. N., Galgiani J. N. Decrease in nosocomialClostridium difficile-associated diarrhea by restricting clindamycin use. Ann. Intern. Med. 120 (1994) 272–277.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Slevog, H., Ruf, B. Antibiotic-associated diarrhea in HIV-infected patients receiving clindamycin. Infection 25, 189 (1997). https://doi.org/10.1007/BF02113612
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02113612